Victory for Vexall against Telkom’s BCX over pharmacy software dominance
The ruling against Telkom’s subsidiary will remain in force for six months
12 February 2020 - 17:08
The Competition Tribunal has ruled in favour of Dis-Chem-backed technology company Vexall to stop Telkom subsidiary Business Connexion (BCX) from abusing its dominant position in the pharmacy software industry.
On Wednesday, the tribunal said BCX is prohibited from selling or offering a licence for its “Unisolv” software on condition that a customer purchase value-added services from BCX. ..
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Commenting is subject to our house rules.
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now